Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and Yamagata

This work is devoted to the research of the live attenuated influenza vaccine (LAIV) comprising two reassortant B/USSR/60/69-based vaccine influenza viruses Victoria and Yamagata. the intranasal immunization of the CBA mice with both victoria and yamagata strains induced 100% lung protection against...

Full description

Bibliographic Details
Main Authors: Yu. A. Desheva, T. A. Smolonogina, E. M. Doroshenko, L. G. Rudenko
Format: Article
Language:English
Published: Central Research Institute for Epidemiology 2016-02-01
Series:Вопросы вирусологии
Subjects:
Online Access:https://virusjour.crie.ru/jour/article/viewFile/298/176
_version_ 1797782247821017088
author Yu. A. Desheva
T. A. Smolonogina
E. M. Doroshenko
L. G. Rudenko
author_facet Yu. A. Desheva
T. A. Smolonogina
E. M. Doroshenko
L. G. Rudenko
author_sort Yu. A. Desheva
collection DOAJ
description This work is devoted to the research of the live attenuated influenza vaccine (LAIV) comprising two reassortant B/USSR/60/69-based vaccine influenza viruses Victoria and Yamagata. the intranasal immunization of the CBA mice with both victoria and yamagata strains induced 100% lung protection against the subsequent infection with the wild-type influenza B viruses of any antigen lineage. the quadrivalent LAIV (qLAIV) comprising both reassortant influenza B viruses Victoria and Yamagata were safe and areactogenic in adult volunteers. Following qLAIV administration the immune response was achieved to both Victoria and Yamagata lineages.
first_indexed 2024-03-13T00:08:18Z
format Article
id doaj.art-ff7356ede2184a089df804905230a5a3
institution Directory Open Access Journal
issn 0507-4088
2411-2097
language English
last_indexed 2024-03-13T00:08:18Z
publishDate 2016-02-01
publisher Central Research Institute for Epidemiology
record_format Article
series Вопросы вирусологии
spelling doaj.art-ff7356ede2184a089df804905230a5a32023-07-12T20:03:15ZengCentral Research Institute for EpidemiologyВопросы вирусологии0507-40882411-20972016-02-01611162010.18821/0507-4088-2016-61-1-16-20252Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and YamagataYu. A. Desheva0T. A. Smolonogina1E. M. Doroshenko2L. G. Rudenko3Institute of Experimental MedicineInstitute of Experimental MedicineInstitute of Experimental MedicineInstitute of Experimental MedicineThis work is devoted to the research of the live attenuated influenza vaccine (LAIV) comprising two reassortant B/USSR/60/69-based vaccine influenza viruses Victoria and Yamagata. the intranasal immunization of the CBA mice with both victoria and yamagata strains induced 100% lung protection against the subsequent infection with the wild-type influenza B viruses of any antigen lineage. the quadrivalent LAIV (qLAIV) comprising both reassortant influenza B viruses Victoria and Yamagata were safe and areactogenic in adult volunteers. Following qLAIV administration the immune response was achieved to both Victoria and Yamagata lineages.https://virusjour.crie.ru/jour/article/viewFile/298/176live influenza vaccineinfluenza bimmunogenicity
spellingShingle Yu. A. Desheva
T. A. Smolonogina
E. M. Doroshenko
L. G. Rudenko
Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and Yamagata
Вопросы вирусологии
live influenza vaccine
influenza b
immunogenicity
title Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and Yamagata
title_full Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and Yamagata
title_fullStr Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and Yamagata
title_full_unstemmed Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and Yamagata
title_short Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and Yamagata
title_sort development of the quadrivalent live attenuated influenza vaccine including two influenza b lineages victoria and yamagata
topic live influenza vaccine
influenza b
immunogenicity
url https://virusjour.crie.ru/jour/article/viewFile/298/176
work_keys_str_mv AT yuadesheva developmentofthequadrivalentliveattenuatedinfluenzavaccineincludingtwoinfluenzablineagesvictoriaandyamagata
AT tasmolonogina developmentofthequadrivalentliveattenuatedinfluenzavaccineincludingtwoinfluenzablineagesvictoriaandyamagata
AT emdoroshenko developmentofthequadrivalentliveattenuatedinfluenzavaccineincludingtwoinfluenzablineagesvictoriaandyamagata
AT lgrudenko developmentofthequadrivalentliveattenuatedinfluenzavaccineincludingtwoinfluenzablineagesvictoriaandyamagata